Surprising Prognosis for Normal ACS

St elevation acute coronary syndromes are typically caused by thrombotic obstruction of a coronary artery due to ruptured atherosclerosis plaque.

Sorpresivo pronóstico para los infartos con coronarias normales

However, there is a significant number of patients with similar clinical presentations but no evidence of obstructive coronary artery disease (CAD).


Read also: CTO in patients with acute myocardial infarction increases long term mortality.


In general, patients without obstructive CAD have better survival, but this might vary substantially depending on the underlying cause and risk factors.

 

The present study included 4793 consecutive patients undergoing ST elevation MI.  88% of these patients had obstructive CAD (≥50% stenosis), 6% had no obstructive CAD (1-49% stenosis) and 5% presented absolutely normal coronary arteries.

 

Patients without CAD were mostly young women with few risk factors. Follow up reached mean 2.6 years.


Read also: Primary angioplasty and multivessel lesions: how should we proceed?


Short term mortality (30 days) was lower both for patients with non-obstructive CAD (HR 0.49; p=0.0018) and for patients with normal coronary arteries (HR 0.31; p=0.021), compared to patients with obstructive CAD.

 

But surprisingly (and just the opposite of what was observed at 30 days) long term mortality with non-obstructive CAD resulted similar (HR 1.15; p=0.48), and for those with normal coronary arteries, it resulted significantly higher (HR 2.44; p<0.001) than that of patients with typical MI (even after adjusting by troponin level).

 

Cause of death was cardiovascular in 70% of cases with typical infarction, but in patients with non-obstructive CAD, it was only 38%, and 32% in patients with normal arteries.


Read also: Is Emergency Cardiac Surgery Necessary in TAVR?


In a population matched by sex and age, mortality resulted superior in patients with non-obstructive CAD.

 

Conclusion

Patients undergoing ST elevation MI that do not present significant obstruction to their coronary arteries have similar and even superior mortality than patients with typical MI. These data suggest that treating these patients involve far more than the routine angiography, and that it should include medication and close follow-up.

 

Original title: Long-term survival and causes of death in patients with ST-elevation acute coronary syndrome without obstructive coronary artery disease.

Reference: Hedvig Bille Andersson et al. Eur Heart J. 2018 Jan 7;39(2):102-110.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...